Register

Module I

Peptide Therapy Certification

–

The Venetian & Palazzo · Las Vegas, Nevada

$2,250 allied health · $2,750 physician · 3 days

Clinician consulting with a smiling couple
  • Metaflammation & metabolic signaling
  • FDA, quality & state-by-state status
  • Sterile product quality control
  • Immune modulation & gut repair
  • Mitochondrial peptides
  • Glucose & insulin regulation
  • Cardiometabolic & vascular health
  • 503A bulk substance status
  • Connective tissue & organ repair
  • Cellular senescence
  • Hormone receptor modulation
  • Brain inflammation & autoimmune

Join the leaders in advanced anti-aging medicine.

Peptide therapies are increasingly playing a significant role in disease state management, performance health and anti-aging strategies. In clinical practices across the globe, peptide therapies are being used to care for cancer, infectious diseases, metabolic disorders, injuries, aesthetic medicine and much more.

The Peptide Therapy Certification program presented in 2 modules, highlights this most relevant and applicable therapy in medicine. Participants can expect to gain extensive knowledge in legal considerations, strength of evidence and clinical applications to utilize on Monday morning.

Featuring world-class clinicians and researchers, the modules will allow you to further your knowledge in the emerging field of peptides and regenerative medicine and adopting this modality into your clinical practices.

International Peptide Society Membership required for certification. Please learn more here or talk with your A4M Educational Advisor.

Regulatory

Regulatory fluency is part of the curriculum

The landscape is moving in peptides' favor — and reading it is a clinical skill.

2026 brought real movement. In April, FDA removed twelve peptides from Category 2 of the 503A bulks list — a procedural step, not a safety clearance and not permission to compound. In July, its advisory committee recommended six of seven nominated substances for the Bulks List, against FDA staff recommendations.

Rulemaking takes time, and each peptide has its own standing. That's why regulatory literacy is taught alongside the clinical content here, not bolted on. You'll leave able to determine where any peptide stands, vet a compounding pharmacy, document appropriately, and explain it all to a patient who read something different online.

Curriculum

The peptides we cover.

Module I addresses the peptides your patients are actually asking about, including the twelve at the center of FDA's 2026 reclassification.

Regenerative & reparative peptides

BPC-157: Promotes healing, angiogenesis, and reduces inflammation; used for GI repair, tissue regeneration, and nervous system recovery.

Thymosin Beta-4 (TB4): Supports cell migration, wound healing, neuroregeneration, and tissue remodeling.

KPV (Lysine-Proline-Valine): Tripeptide with anti-inflammatory effects; supports gut integrity, wound healing, and mast cell stabilization.

RGN-259: A TB4-derived peptide under study for treating neurotrophic keratitis.

Neuroprotective & cognitive peptides

VIP (Vasoactive Intestinal Peptide): Modulates neuroimmune function, reduces inflammation, and supports circadian rhythm; used in Chronic Inflammatory Response Syndrome (CIRS).

Selank: Anxiolytic and nootropic; enhances cognition and mood.

PE-22-28: A spadin analog with antidepressant and neurogenic effects.

PT-141 (Bremelanotide): A melanocortin receptor agonist with mood and sexual function benefits.

Growth hormone axis & metabolism

CJC-1295/Ipamorelin: Stimulate growth hormone release; used for sleep, recovery, muscle growth, and cognition.

Sermorelin: GHRH analog for promoting natural GH/IGF-1 production; anti-aging and body composition.

Tesamorelin: GHRH analog used to reduce visceral fat and support cognitive performance and liver health in lipodystrophy and NAFLD.

GHRH / ALRN-5281: Peptides targeting GH axis; related to insulin sensitivity, thymic support, and oxidative stress control.

Appetite, anabolic & energy regulation

Ghrelin / Macimorelin: Appetite-stimulating peptides; Macimorelin is a ghrelin receptor agonist used for GH testing and potential in cachexia.

MOTS-c: Mitochondrial-derived peptide; boosts insulin sensitivity and supports metabolic health.

Nicotinamide Riboside (NR): NAD+ precursor enhancing mitochondrial function and cognitive resilience (not a peptide per se, but often used in peptide protocols).

Gut & barrier function peptides

Larazotide (AT-1001): Regulates tight junctions for intestinal permeability and is used in leaky gut, celiac disease, and autoimmune conditions.

Metabolic & cardiovascular peptides

GLP-1 agonists (Semaglutide, Tirzepatide, Liraglutide, Dulaglutide, Exenatide, Lixisenatide): Regulate blood sugar, reduce weight, and exhibit neuroprotective effects. Tirzepatide acts on dual GLP-1/GIP pathways.

Immune modulation peptides

Thymosin Alpha-1 (TA1): Boosts immune function; effective in viral infections, immune aging, and chronic inflammation.

Low Dose Naltrexone (LDN): Though not a peptide, it is frequently co-administered in peptide protocols for managing autoimmunity and chronic inflammation.

Amino-acid-based & signaling compounds

SPMs (Specialized Pro-Resolving Mediators): While technically not peptides, included for their overlapping use in inflammation resolution.

Wheat-Bran Peptides (LRP & LQP): Leucine-rich; studied for NASH and oxidative stress, AMPK activation, and mitochondrial function.

Inflammation-modulating & adjunctive compounds

IRW Peptide: Ovotransferrin-derived; anti-inflammatory, supports PGC1α and mitochondrial metabolism.

TUDCA: Bile acid derivative often used with peptides in neurodegenerative and metabolic protocols.

Clinical use categories

Eight focus areas mapping each peptide to the clinical use it's reached for.

Tissue repair

  • BPC-157
  • TB4
  • KPV
  • RGN-259

Neurocognitive health

  • VIP
  • Selank
  • PE-22-28
  • PT-141
  • NR

GH axis & recovery

  • CJC/Ipamorelin
  • Sermorelin
  • Tesamorelin

Energy & metabolism

  • MOTS-c
  • Ghrelin
  • Macimorelin

Gut/barrier function

  • Larazotide
  • KPV

Metabolic regulation

  • GLP-1 agonists (e.g., Tirzepatide)

Immune modulation

  • TA1
  • LDN
  • KPV
  • VIP

Mitochondrial support

  • NR
  • IRW
  • LRP/LQP
  • TUDCA

Faculty

Learn from clinicians in the trenches.

Eleven physicians, pharmacists and regulatory specialists who prescribe, compound and defend peptide therapy in their own practices.

Each session is taught by the person doing that work, from FDA compliance and sterile manufacturing to metabolic and regenerative protocols.

Tyler Chamberlain, PharmD, FAPC

Tyler Chamberlain, PharmD, FAPC

Compounding pharmacist · regulatory compliance

With a Doctor of Pharmacy degree from Purdue University and extensive experience as a Pharmacist in Charge and Chief of Regulations and Compliance, I bring a unique blend of expertise in sterile and nonsterile compounding, regulatory compliance, and quality assurance. My proficiency encompasses a broad spectrum of skills including formulation of standard operating procedures, mastery in compounding techniques for hazardous drugs, and ensuring compliance with FDA, DEA, and state regulations. Certified in Sterility Assurance from PCCA and licensed in multiple states, my knowledge and experience position me as a valuable resource in navigating the complex landscape of pharmacy law and compounding practices.

Gordon Crozier, DO

Gordon Crozier, DO

Medical Director, Crozier Clinic · A4M lead educator

A pioneer of genetics-based integrative medicine and Medical Director of Crozier Clinic in Orlando. Clinical faculty at the University of Kentucky, lead educator and curriculum developer for A4M, and a steering committee member of the International Peptide Society — he has trained over 250 centers nationwide in peptide therapy.

Lectures nationally on Lyme disease, mold-related illness, peptide science and glutathione; author of Healing One Cell at a Time, Ticked Off and Heal Your Cells.

Marisol Duque, MD

Marisol Duque, MD

Integrative & bio-regenerative medicine

A medical surgeon with more than 18 years caring for patients across Latin America and Europe, specializing in integrative and bio-regenerative medicine, tissue regeneration, longevity, homotoxicology, neural therapy, and cardiovascular health.

Has treated over 10,000 patients and pioneered a regeneration technique that mimics the body’s own capacity to heal.

Ben Greenfield, MS, CSCS, C-PT, C-ISSN

Ben Greenfield, MS, CSCS, C-PT, C-ISSN

Ben Greenfield, MS, CSCS, C-PT, C-ISSN is founder of Kion, Ben Greenfield Life, and LIFE OS, and globally renowned as a leader in health, fitness, and human performance whose mission is to help others become boundless—free from the constraints of time, energy, and knowledge. A New York Times bestselling author, Ben's work reaches millions of people every month through a powerful combination of podcasting, writing, speaking, and coaching. His books, such as Boundless and Beyond Training, have become essential guides for anyone looking to optimize their energy levels and achieve a life of boundless vitality.

Ben's journey into the world of health began with an insatiable drive to understand how the human body and mind can operate without limits. Armed with a degree in Sports Science and certifications in personal training, strength and conditioning, and sports nutrition, Ben quickly rose to prominence as a leader in the field. Over the past two decades, he has competed in 13 Ironman triathlons and worked with countless individuals—including executives, entrepreneurs, and athletes—to help them break free from the shackles of exhaustion, burnout, and lack of motivation.

Ben's approach to health and wellness is designed to empower people to live boundless lives—where energy is abundant, motivation is constant, and limits are nonexistent. His expertise has been sought by top media outlets, and his insights have been featured in Men's Health, Fox News, CBS, The New York Times, and Outside Magazine. But what truly sets Ben apart is his ability to translate complex scientific concepts into practical, actionable advice that enables anyone to achieve boundless energy and peak performance.

In addition to his content creation and coaching, Ben is the co-founder of Kion, a company dedicated to advancing human health through high-quality supplements and wellness products. Kion embodies Ben's commitment to helping people achieve more than they ever thought possible, providing the tools needed to live a boundless life.

Ben is also the co-founder of LIFE OS, a health operating system unifying labs, wearables, and clinician care in one platform.

Ben serves as an advisor and board member for multiple respected companies in the global wellness space, including the luxurious St. Haven Clubs by Gurner Group, Next Health, Agentis Longevity, Muse Cell Innovations, and Vesalius.

His new documentary, Boundless: The Man Who Became Human, executive produced by Zac Efron, follows 20 years of teaching the world how to master the body and what that mastery couldn't reach. It's available to stream now.

Whether through his books, podcast, or coaching, Ben Greenfield doesn't just teach you how to be healthier—he shows you how to become boundless. He is the guide you've been looking for, the mentor who will help you shatter your limits, and the inspiration you need to live a life of extraordinary energy, clarity, and purpose. Connect with Ben, and embark on your journey to becoming boundless, where your energy knows no bounds and your potential is limitless.

Abid Husain, MD, FACC, ABAARM

Abid Husain, MD, FACC, ABAARM

Cardiologist · preventive & metabolic cardiology

A board-certified cardiologist with more than two decades of practice in Colorado and Nevada, focused on advanced lipid disorders, atherosclerosis and long-term cardiovascular risk reduction.

Completed A4M’s Fellowship in Anti-Aging, Integrative and Metabolic Medicine and lectures on the cardiovascular case for metabolic and peptide therapies.

James LaValle, RPh, CCN

James LaValle, RPh, CCN

Clinical pharmacist · integrative & precision medicine

A clinical pharmacist and internationally recognized expert in integrative and precision medicine, with over three decades spent bridging pharmacology, nutrition and metabolic science to build individualized treatment protocols.

Author and educator on peptide therapy, hormone optimization and precision supplementation; has trained thousands of clinicians nationwide.

Kathleen O’Neil-Smith, MD, FAARM

Kathleen O’Neil-Smith, MD, FAARM

Functional, integrative & regenerative internal medicine

A magna cum laude graduate of Boston University School of Medicine, with postgraduate training at Massachusetts General Hospital and Brigham and Women’s Hospital. Moved into functional and regenerative medicine in 2008.

An international thought leader in regenerative and peptide therapies who teaches worldwide; former member and coach of the US Women’s National Rowing Team.

Lee Rosebush, PharmD, JD, MBA

Lee Rosebush, PharmD, JD, MBA

Partner, BakerHostetler · FDA & compounding law

A regulatory and patent attorney who previously worked as a registered pharmacist, now leading BakerHostetler’s pharmacy and reimbursement team and co-leading its FDA practice.

Speaks and writes widely on the Drug Quality and Security Act and FDA regulation of pharmacy compounding, with deep experience in 503A and 503B matters.

Erika Schwartz, MD

Erika Schwartz, MD

Founder, Evolved Science · A4M faculty

Dr. Erika Schwartz takes the best of conventional and integrative medicine and applies these principles to preventing disease.

For more than 30 years, Dr. Erika has been at the forefront of advanced patient care. She was one of the first doctors in the US to treat patients with bio-identical hormones and administer preventative IVs, and now she is on the forefront of prescribing peptide therapy, the next frontier of anti-aging medicine.

For Dr. Erika, work is pure joy, her legacy is to improve healthcare for the individual and remove fear and arrogance from the system. She continues to deliver cutting-edge care to all of her patients in a warm, friendly office.

Dr. Erika is a graduate of NYU, and she received her MD from SUNY-Downstate College of Medicine Cum Laude. She is a member of the prestigious Alpha Omega Alpha honor society and has authored six best-selling books for the public along with medical articles and numerous blogs, YouTube channel and bylined articles in the highest circulation publications of the world. She teaches providers as faculty at The American Academy of Anti-Aging Medicine and the International Peptide Society.

Melissa Stefko, MBA, MS, RAC, ASQ CPGP & CQA

Melissa Stefko, MBA, MS, RAC, ASQ CPGP & CQA

SVP Regulatory, Wells Pharmacy Network

Melissa Stefko is the Senior Vice President of Regulatory at Wells Pharmacy Network, a leading national provider of high-quality compounded medications. With experience in Quality Assurance and Quality Control, Melissa began her career as a microbiologist and has been working in the pharmaceutical industry since 2008. She recently moved into the professional services industry, where she helps pharmaceutical manufacturers add value to their operations.

Melissa holds a Bachelor's degree in Biology with a Minor in Chemistry from Florida State University, where she co-founded the Pre-Pharmacy Informational Leadership and Learning Society. She continued her education by obtaining a Master's in Business Administration, a Master's of Science in Biotechnology, and a Regulatory Affairs Certificate from the University of Maryland Global Campus. She is also certified as a Quality Auditor and GMP Professional through ASQ.

In addition to her work, Melissa is a member of several organizations, including the Regulatory Committee for the Alliance for Pharmacy Compounding, her local ASQ and RAPS Chapters, and a Board Member for the Alliance for Pharmacy Compounding and Tampa Bay Skating Club. She believes in advancing the pharmaceutical industry through collaboration and knowledge sharing as well as expanding patient access to medications.

Elizabeth Yurth, MD, FAARFM, ABAARM

Elizabeth Yurth, MD, FAARFM, ABAARM

Medical Director, Boulder Longevity Institute

Elizabeth Yurth is a double board-certified physician in Physical Medicine and Rehabilitation and Anti-Aging and Regenerative Medicine, and one of the earliest physicians in the United States to bring peptide therapeutics into responsible clinical practice. Fellowship-trained in spine and sports medicine at a Stanford-affiliated group, she served as a team physician for Stanford and Santa Clara University and consulted for the San Francisco 49ers before turning her focus to the cellular science of aging.

For twenty years she has led Boulder Longevity Institute, which she co-founded as one of the first full-spectrum longevity clinics in the world, integrating hormone optimization, peptide therapy, regenerative orthopedics, and cellular medicine. Her work centers on a pathway-first model that targets the cellular machinery of aging, from mitochondrial function to autophagy and inflammatory signaling. She has played a foundational role in developing the clinical frameworks, dosing strategies, and safety protocols many practitioners now rely on, and through her Human Optimization Academy she has trained clinicians worldwide in peptide and hormone therapeutics. She holds faculty appointments with IPS, Longevity Docs, and nuBioAge.

In 2026 she was invited to present testimony before the FDA's Pharmacy Compounding Advisory Committee on the therapeutic use of compounded peptides, drawing on three decades of clinical experience to translate emerging science into protocols clinicians can use safely.

The agenda.

Three days in Las Vegas, December 11–13, 2026. Day one grounds you in the science, the regulatory landscape and quality standards. Day two works through metabolism, immunity and cardiovascular health. Day three covers legal access, tissue repair, hormones and real patient cases.

Choose a day to see each session, its faculty and learning objectives.

Day 1 · Friday, December 11, 2026

7:30–8:30 am

Peptides Overview: Controlling Metaflammation, Metabolic Signaling & Clinical Value

James LaValle, RPh, CCN, MT, DHM, DHPh

learning objectives
  • Define the concept of metaflammation and its impact on aging and chronic disease.
  • Identify key peptide targets in modulating metabolic and inflammatory pathways.

8:30–10:00 am

Don’t miss

FDA, Quality Assurance, and State to State Status: Where Are We Now and Where Is It Going?

Melissa Stefko, MBA, MS, RAC, ASQ CPGP & CQA

learning objectives
  • Review current FDA regulations and quality standards related to peptide therapies.
  • Understand state-specific variability and its implications for clinical practice.
  • Identify common legal risks in prescribing and compounding peptides.
  • Outline best practices to protect both patients and clinicians.

10:00–10:30 am

Break

10:30 am–12:00 pm

Manufacturing of Sterile Product Quality Control: Understanding the “For Human Use Difference”

Tyler Chamberlain, PharmD

learning objectives
  • Distinguish between sterile vs. non-sterile peptide compounding processes.
  • Understand the regulatory implications of using peptides for human applications.

12:00–1:30 pm

Lunch sponsored by Thesis Pharmacy

Peptides in Practice: What Physicians Need to Know Now (Non-CME)

Kris Wusterhausen, DO

1:30–2:00 pm

Manufacturing of Sterile Product Quality Control: Continued

Tyler Chamberlain, PharmD

learning objectives
  • Dive deeper into aseptic techniques and risk-based quality assessment in peptide production.

2:00–3:00 pm

Integrating Peptides into Clinical Practice

Erika Schwartz, MD

learning objectives
  • Discuss patient selection and monitoring strategies.
  • Identify key peptides for different clinical goals and conditions.

3:00–3:30 pm

Break

3:30–5:00 pm

Global Lifestyle Considerations in Peptide Medicine

James LaValle, RPh, CCN, MT, DHM, DHPh

learning objectives
  • Explore how lifestyle, diet, and environment affect peptide outcomes.
  • Understand patient-centric strategies to enhance response and compliance.

5:00–6:00 pm

SARMs – What Are They: Science and Controversy

Elizabeth Yurth, MD

learning objectives
  • Define SARMs and differentiate them from traditional peptide therapies.
  • Review clinical and ethical considerations surrounding their use.

6:00 pm

Close of session

Day 2 · Saturday, December 12, 2026

7:30–9:30 am

Don’t miss

Body Composition and Metabolism

Gordon Crozier, DO

learning objectives
  • Explore advanced cycling strategies for performance and fat loss.
  • Incorporate peptide protocols into personalized body composition plans.

9:30 am–10:00 am

Leveling Up the Human Machine: Biohacker Insights on Peptide Therapies (Non-CME) 

Ben Greenfield, MS, CSCS, C-PT, C-ISSN

10:00–10:30 am

Break

10:30 am–12:00 pm

All Roads of Health Lead to Immune Modulation and Gut Repair

James LaValle, RPh, CCN, MT, DHM, DHPh

learning objectives
  • Recognize the role of immune peptides in gut restoration and immune balance.
  • Implement targeted gut-healing protocols using peptide-based strategies.

12:00–1:30 pm

Lunch

1:30–2:30 pm

Mitochondrial Peptides: Cellular Energy, Metabolic Signaling & Healthy Aging

Elizabeth Yurth, MD

learning objectives
  • Explain how mitochondrial-derived and mitochondria-targeted peptides influence cellular energy, metabolic signaling and aging.
  • Identify clinical applications, patient selection and monitoring considerations for mitochondrial peptide therapy.

2:30–3:30 pm

The Role of Peptides in Glucose and Insulin Regulation – Balancing the Seesaw

James LaValle, RPh, CCN, MT, DHM, DHPh

learning objectives
  • Identify peptides that influence glucose metabolism and insulin sensitivity.
  • Apply protocols for addressing metabolic dysfunction.

3:30–4:00 pm

Break

4:00–5:00 pm

The Cardiometabolic Axis: Peptides for Vascular Health, Endothelial Function & Cardiovascular Risk Reduction

Abid Husain, MD

learning objectives
  • Describe the cardiometabolic continuum linking metaflammation, insulin resistance, and cardiovascular risk.
  • Identify peptides with cardioprotective and endothelial signaling effects and apply foundational strategies for cardiovascular risk reduction.

5:00–6:00 pm

What’s New? Peptides and Bioregulators

James LaValle, RPh, CCN, MT, DHM, DHPh

learning objectives
  • Understand the emerging science of bioregulators and their intersection with peptides.
  • Explore novel therapeutic targets in cellular signaling.

6:00 pm

Close of session

Day 3 · Sunday, December 13, 2026

7:30–8:30 am

Don’t miss

Restoring Legal Access: 503A Bulk Substance Status, the PCAC Decisions & the Path Forward for Peptide Medicine

Lee Rosebush, PharmD, JD, MBA

learning objectives
  • Trace the regulatory arc from the 2023 Category 2 listing through the 2026 de-listing and Pharmacy Compounding Advisory Committee review, and explain the current compounding status of BPC-157, TB-500, KPV, MOTS-C, DSIP, Semax and Epitalon.
  • Distinguish legally compounded 503A/503B peptide sourcing from gray-market and international channels using USP <795> and <797> quality standards.
  • Apply sourcing, prescribing and documentation practices that support patient safety and reduce clinician regulatory exposure.

8:30–10:00 am

Optimize the Body to Heal from Injury: Connective Tissue & Organ Repair

Kathleen O’Neil-Smith, MD

learning objectives
  • Understand the mechanisms of peptides in musculoskeletal and organ healing.
  • Identify key peptide protocols for injury recovery and regenerative therapy.

10:00–10:30 am

Break

10:30–11:30 am

Cellular Senescence: DNA Damage, Telomeres & Zombie Cells

Kathleen O’Neil-Smith, MD

learning objectives
  • Define cellular senescence and its relationship with aging.
  • Review peptides that influence telomere stability and senescence reversal.

11:30 am–12:30 pm

Hormone Signaling and Hormone Receptor Modulation

Marisol Duque, MD

learning objectives
  • Understand the role of peptide therapy in modulating hormone receptor activity.
  • Explore therapeutic opportunities in endocrine restoration and optimization.

12:30–1:30 pm

Lunch

1:30–2:30 pm

Hormone Signaling and Hormone Receptor Modulation (Cont.)

Marisol Duque, MD

2:30–3:30 pm

Intro to Brain Inflammation and Autoimmune

Kathleen O’Neil-Smith, MD

learning objectives
  • Explore the role of neuropeptides in neuroinflammation and immune modulation.
  • Discuss therapeutic approaches for early neurodegenerative conditions.

3:30–4:00 pm

Break

4:00–5:00 pm

Patient Case Panel

Faculty panel co-led by J. LaValle & E. Yurth

learning objectives
  • Apply learnings through real-world case reviews.
  • Evaluate and discuss personalized peptide protocols across conditions.

5:00 pm

Close of session

Draft agenda. Times and faculty subject to change.

Join us this December in Las Vegas
and bring peptide therapy in-house.

Allied Health

Registration $2,250 USD

Register

Physician

Registration $2,750 USD

Register

Pricing reflects registration for Module I. Allied Health includes nurse practitioners, physician assistants, and nurses.

Venue

Venue information.

Every session takes place at the center of the Las Vegas Strip.

Event venue & host hotel

The Venetian & Palazzo Resort

3355 S. Las Vegas Blvd. · Las Vegas, NV 89109

Call center
Toll-free
International
Local number
Cutoff Date
November 13, 2026
Book your room

Limited availability. Room rates vary.

Please see additional room availability below. 

Stay

Hotel information.

Rooms at the host hotel are limited. Our group room blocks are also available at Treasure Island Las Vegas and Wynn and Encore Las Vegas.

Group hotel

Treasure Island Las Vegas

3300 Las Vegas Blvd S · Las Vegas, NV 89109

Group name
A4M Longevity Fest
Group code
A4MLF
Cutoff date
Nov 16, 2026
Book early to secure
Reservations
Book your room

*Room rates vary and are subject to availability.

Group hotel

Wynn and Encore Las Vegas

3131 Las Vegas Blvd. S. · Las Vegas, NV 89109

Cutoff date
Nov 18, 2026
Reservations
Book your room